← Top stories
Legal▼ Bearish for Indian equities
Hospital stocks: can strong demand offset regulatory risks?
The brief
- Supreme Court scrutiny of medicine mark-ups has raised concerns over hospital margins
- Robust demand for tertiary care continues to support hospitals
- Margin risks and care demand affect Indian hospital operators
- Supreme Court allows new-generation joint firecrackers: What are they?
- Can CBDT circular override Income Tax Act? Supreme Court gives clear answer
- US Supreme Court to weigh Trump's mandatory immigration detention policy
- Supreme Court Weighs Shield for Oil Companies as New Term Opens
- Facing climate lawsuits, Big Oil again turns to US Supreme Court
Hospital drug markups and pricing regulation concerns
The Supreme Court questioned hospital markups on cancer drugs, including a case where a medicine costing ₹2,700 to retailers was billed at ₹27,000 to patients, and urged a probe. Hospital stocks fell sharply, erasing $2.6 billion in value, as investors weighed possible medicine price curbs.
Friday, 2 October
- Hospital stocks: can strong demand offset regulatory risks?